4 Results for "

E545K

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "E545K" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-11080
CAS No.: 1197160-28-3
Purity:  ≥98.0%
Target:  

PI3K mTOR

Research Areas:  

Cancer

PKI-179 is a potent and orally active dual PI3K/mTOR inhibitor, with IC50s of 8 nM, 24 nM, 74 nM, 77 nM, and 0.42 nM for PI3K-α, PI3K-β, PI3K-γ, PI3K-δ and mTOR, respectively. PKI-179 also exhibits activity over E545K and H1047R, with IC50s of 14 nM and 11 nM, respectively. PKI-179 shows anti-tumor activity in vivo .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-11080A
CAS No.: 1463510-35-1
Purity:  99.66%
Target:  

PI3K mTOR

Research Areas:  

Cancer

PKI-179 hydrochloride is a potent and orally active dual PI3K/mTOR inhibitor, with IC50s of 8 nM, 24 nM, 74 nM, 77 nM, and 0.42 nM for PI3K-α, PI3K-β, PI3K-γ, PI3K-δ and mTOR, respectively. PKI-179 hydrochloride also exhibits activity over E545K and H1047R, with IC50s of 14 nM and 11 nM, respectively. PKI-179 hydrochloride shows anti-tumor activity in vivo .
loading...
    loading...
Cat. No.: HY-P703469
Purity:  ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: PIK3R1&PIK3CA
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-182946
CAS No.: 3115133-30-4
Target:  

PI3K

Research Areas:  

Cancer

PI3Kα-IN-31 is an orally active and selective PI3Kα inhibitor. PI3Kα-IN-31 shows potent preference for mutant PI3Kα over wild-type PI3Kα. PI3Kα-IN-31 exerts antiproliferative effects in PI3Kα-mutant cancer cells. PI3Kα-IN-31 suppresses tumor growth in xenograft models. PI3Kα-IN-31 can be used for the research of breast cancer .
loading...
    loading...